9 terminated. 9 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
| Phase 1 | 2 | Terminated 2 |
Follow Metastatic Prostate Carcinoma: new trials by email Literature Review of Metastatic Prostate Carcinoma trials Research Report on Metastatic Prostate Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer 68Ga-PSMA-11, Positron Emission Tomography (PET) - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | Terminated | Thomas Hope | 15 | 2021-09-28 | 2026-05-15 |
| 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography - Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Terminated | Jonsson Comprehensive Cancer Center | 22 | 2021-06-16 | 2022-10-21 |
| Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer Antiandrogen Therapy, Abiraterone Acetate, Prednisone - Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Terminated | University of Washington | 10 | 2020-06-29 | 2023-10-26 |
| Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer Abiraterone Acetate, Enzalutamide, Erdafitinib - Castration-Resistant Prostate Carcinoma, Double-Negative Prostate Carcinoma | Phase 2 | Terminated | University of Washington | 3 | 2020-04-27 | 2023-09-28 |
| ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981, Nivolumab - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma | Phase 2 | Terminated | Barbara Ann Karmanos Cancer Institute | 10 | 2019-11-13 | 2024-07-16 |
| Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies Carboplatin, Docetaxel - Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma | Phase 2 | Terminated | Seattle Institute for Biomedical and Clinical Research | 2 | 2016-11-01 | 2021-08-05 |
| Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer Ascorbic Acid, Docetaxel, Laboratory Biomarker Analysis - Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma | Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 50 | 2016-06-20 | 2023-06-07 |
| Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Carboplatin, Docetaxel, Laboratory Biomarker Analysis - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 / Phase 2 | Terminated | University of Washington | 28 | 2016-02-29 | 2021-10-01 |
| Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression Enzalutamide, Ribociclib, Laboratory Biomarker Analysis - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 / Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 52 | 2015-12-01 | 2026-04-22 |
Genital Diseases (9) · Genital Diseases, Male (9) · Genital Neoplasms, Male (9) · Male Urogenital Diseases (9) · Neoplasms (9) · Neoplasms by Site (9) · Prostatic Diseases (9) · Urogenital Diseases (9) · Urogenital Neoplasms (9)
Docetaxel (3) · Magnetic Resonance Spectroscopy (3) · Abiraterone Acetate (2) · Carboplatin (2) · benzamide (2) · enzalutamide (2) · gallium 68 PSMA-11 (2) · 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one (1) · 68Ga-DKFZ-PSMA-11 (1) · Acetates (1) · Androgen Antagonists (1) · Ascorbic Acid (1) · Biopsy (1) · Esters (1) · Nivolumab (1)
University of Washington (3) · Barbara Ann Karmanos Cancer Institute (1) · Jonsson Comprehensive Cancer Center (1) · Seattle Institute for Biomedical and Clinical Research (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Thomas Hope (1)
United States (9)
Channing Paller, MD (1) · Elisabeth Heath, M.D. (1) · Ivan A de Kouchovsky, MD (1) · Jeremie Calais, MD (1) · Jing Zeng (1) · Matthew Rettig, MD (1) · Michael Schweizer (1) · Robert B Montgomery, MD (1) · Robert Montgomery (1) · William Kevin Kelly, MD (1)
PMID 39076107, PMID 39420060, PMID 39503807
P50CA097186 (2), P30CA006973 (1), P30CA015704 (1), P30CA022453 (1)